slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13.600 KRW | +0,37% | +5,18% | +18,57% |
29/01 | Zimbabwe start huis-aan-huis choleravaccinatiecampagne | RE |
2023 | Pop Biotechnologies en EuBiologics' Eucorvac-19 vaccin treft doel in Fase 3 studie | CI |
Omzet 2024 * | 116 mld. 84,33 mln. 79 mln. | Omzet 2025 * | 128 mld. 93,06 mln. 87,17 mln. | Marktkapitalisatie | 490 mld. 356 mln. 334 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 29 mld. 21,08 mln. 19,75 mln. | Nettowinst (verlies) 2025 * | 34 mld. 24,72 mln. 23,15 mln. | EV/omzet 2024 * | 4,34 x |
Nettoschuld 2024 * | 14 mld. 10,18 mln. 9,53 mln. | Nettoschuld 2025 * | 14 mld. 10,18 mln. 9,53 mln. | EV/omzet 2025 * | 3,94 x |
K/w-verhouding 2024 * |
16,8
x | K/w-verhouding 2025 * |
14,7
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 80,12% |
1 dag | +0,37% | ||
1 week | +5,18% | ||
Lopende maand | +12,21% | ||
1 maand | +6,50% | ||
3 maanden | +31,40% | ||
6 maanden | +42,41% | ||
Lopend jaar | +18,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yeong-Ok Baek
CEO | Chief Executive Officer | 61 | 01-01-05 |
Suk-Keun Choi
DFI | Director of Finance/CFO | 57 | 01-08-10 |
Kyeong-Ho Min
BRD | Director/Board Member | 55 | 01-12-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Suk-Keun Choi
DFI | Director of Finance/CFO | 57 | 01-08-10 |
Yeong-Ok Baek
CEO | Chief Executive Officer | 61 | 01-01-05 |
Kyeong-Ho Min
BRD | Director/Board Member | 55 | 01-12-10 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 13.600 | +0,37% | 753 981 |
22-04-24 | 13.550 | +6,61% | 5 191 208 |
19-04-24 | 12.710 | +0,39% | 453 331 |
18-04-24 | 12.660 | +0,88% | 315 390 |
17-04-24 | 12.550 | -2,94% | 605 274 |
slotkoers Korea S.E., 23 april 2024
Meer koersenHerzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,57% | 361 mln. | |
-2,86% | 87,37 mld. | |
+4,08% | 41,01 mld. | |
-25,35% | 28,08 mld. | |
+53,93% | 24,72 mld. | |
-4,52% | 17,47 mld. | |
-42,09% | 11,69 mld. | |
-17,77% | 11,6 mld. | |
-12,10% | 11,56 mld. | |
+1,57% | 8,44 mld. |